Case Study: Top 10 Pharmaceutical Manufacturer achieves a clear commercialization roadmap and launch readiness with IntegriChain (Blue Fin Group)

Commercial Stakeholder Mapping – Blueprinting for Success

A Top 10 Pharmaceutical Manufacturer preparing to launch a complex oncology combination regimen with two novel agents faced several commercial unknowns—including site-of-care strategy, anticipated payer management, and physician buy-and-bill preferences—and was relatively new to specialty oncology. The customer engaged IntegriChain (via Blue Fin Group) to begin commercial product planning by mapping the stakeholder journey and assessing early commercial buying-process implications.

IntegriChain’s Blue Fin Group conducted robust primary research and developed a holistic commercial stakeholder journey map that integrated the clinical patient pathway, product flow, and provider and payer journeys to serve as a launch blueprint. The work revealed previously unrecognized treatment-journey nuances, prompted significant revisions to the client’s initial launch assumptions, identified site of care as a critical commercial enabler, and delivered a clear roadmap including a five‑year multigenerational strategic plan—leading the Top 10 Pharmaceutical Manufacturer to request further functional-level launch strategy and implementation support from IntegriChain.